Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / KRYS - Krystal Clear: KB-103 Sprints To Become The First Approved Topical Gene Therapy For Skin Disease


KRYS - Krystal Clear: KB-103 Sprints To Become The First Approved Topical Gene Therapy For Skin Disease

Editor's note: Seeking Alpha is proud to welcome Miguel Costa Coelho as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to SA Essential. Click here to find out more »

Imagine you could heal genetic conditions by applying lotion to your skin, like sun-lotion to cool down the burn after a long day at the beach. Krystal Biotech (KRYS) is making this possible, with interesting value catalysts for 2020 (KB-103 top-line Phase 2/3 data and KB-105

Read more ...

Stock Information

Company Name: Krystal Biotech Inc.
Stock Symbol: KRYS
Market: NASDAQ
Website: krystalbio.com

Menu

KRYS KRYS Quote KRYS Short KRYS News KRYS Articles KRYS Message Board
Get KRYS Alerts

News, Short Squeeze, Breakout and More Instantly...